JGGDR
NGNE icon

JGP Global Gestao de Recursos’s Neurogene NGNE Stock Holding History

JGP Global Gestao de Recursos’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-569
Closed -$188K – 34
2016
Q4 		$188K Buy
+569
New +$153K 0.1% 41

Other funds holding NGNE

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

JGP Global Gestao de Recursos's NGNE Position: Q1 2017 in Review

JGP Global Gestao de Recursos sold out of Neurogene (NGNE) in Q1 2017, closing a stake of 569 shares — an estimated $188K sold.

JGP Global Gestao de Recursos first reported a position in NGNE in Q4 2016 and held it in 1 quarter. The position peaked at $188K in Q4 2016. 39 funds tracked by Wall St. Rank hold NGNE as of Q1 2017.

  • JGP Global Gestao de Recursos reported no remaining Neurogene position as of Q1 2017 after selling out during the quarter.
  • JGP Global Gestao de Recursos sold 569 Neurogene shares in Q1 2017, an estimated $188K.
  • JGP Global Gestao de Recursos first reported a position in Neurogene in Q4 2016 and held it in 1 quarter.
  • JGP Global Gestao de Recursos's Neurogene position peaked at $188K in Q4 2016.
  • 39 funds tracked by Wall St. Rank held Neurogene as of Q1 2017.

Based on JGP Global Gestao de Recursos's 13F filing for Q1 2017, filed 9 May 2017.